Receipt of formal meeting minutes from the FDA confirming key elements for two proposed Phase 3 pivotal trials indicates regulatory progress and alignment with the FDA. Positive outcome of the ...
Clearside Biomedical announces upcoming presentations on CLS-AX sub-group analyses from the ODYSSEY Wet AMD trial at various conferences. Clearside Biomedical, Inc. announced upcoming presentations ...
The Chosun Ilbo on MSN
SK AX expands AI training to Gwangju, Ulsan
SK AX expands AI talent development regions nationwide. SK AX announced on the 7th that it will broaden its educational bases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results